Based on the Azenta Inc stock forecast from 3 analysts, the average analyst target price for Azenta Inc is USD 58.80 over the next 12 months. Azenta Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Azenta Inc is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, Azenta Inc’s stock price was USD 41.53. Azenta Inc’s stock price has changed by -5.57% over the past week, -15.40% over the past month and -15.31% over the last year.
No recent analyst target price found for Azenta Inc
No recent average analyst rating found for Azenta Inc
Company Overview Azenta Inc
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts. Address: 200 Summit Drive, Burlington, MA, United States, 01803 Read Less
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segme...Read More
Frequently Asked Questions About Azenta Inc (AZTA) Stock
Based on ratings from 3 analysts Azenta Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on AZTA's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for AZTA is USD 58.80 over the next 12 months. The maximum analyst target price is USD 69 while the minimum anlayst target price is USD 50.
AZTA stock's Price/Earning ratio is 1.57.
Our analysis grades AZTA stock's Price / Earning ratio at A. This means that AZTA stock's Price/Earning ratio is above 6.999999999999995% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this AZTA may be undervalued for its sector.
The last closing price of AZTA's stock was USD 41.53.
The most recent market capitalization for AZTA is USD 2.13B.
Based on targets from 3 analysts, the average taret price for AZTA is projected at USD 58.80 over the next 12 months.
This means that AZTA's stock price may go up by +41.58% over the next 12 months.
We can't find any ETFs which contains Azenta Inc's stock.
As per our most recent records Azenta Inc has 3,300 Employees.
Azenta Inc's registered address is 200 Summit Drive, Burlington, MA, United States, 01803.
You can get more information about it from Azenta Inc's website at https://www.azenta.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Azenta Inc (AZTA) Stock
Based on ratings from 3 analysts Azenta Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Neutral. The stock has 2 buy, sell and 3 hold ratings.
Unfortunately we do not have enough data on AZTA's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for AZTA is USD 58.80 over the next 12 months. The maximum analyst target price is USD 69 while the minimum anlayst target price is USD 50.
AZTA stock's Price/Earning ratio is 1.57.
Our analysis grades AZTA stock's Price / Earning ratio at A. This means that AZTA stock's Price/Earning ratio is above 6.999999999999995% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this AZTA may be undervalued for its sector.
The last closing price of AZTA's stock was USD 41.53.
The most recent market capitalization for AZTA is USD 2.13B.
Based on targets from 3 analysts, the average taret price for AZTA is projected at USD 58.80 over the next 12 months.
This means that AZTA's stock price may go up by +41.58% over the next 12 months.
We can't find any ETFs which contains Azenta Inc's stock.
As per our most recent records Azenta Inc has 3,300 Employees.
Azenta Inc's registered address is 200 Summit Drive, Burlington, MA, United States, 01803.
You can get more information about it from Azenta Inc's website at https://www.azenta.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AZTA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
